Last reviewed · How we verify
NCT04255706
Repeatability in Measurements of Two ssOCT and One OLCR Biometer
NA trial testing biometric measurement IOLMaster 700 in Cataract Senile in 50 participants. Completed in 1 April 2020.
1 April 2020
Quick facts
| Lead sponsor | Prim. Prof. Dr. Oliver Findl, MBA |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | diagnostic |
| Enrollment | 50 |
| Start date | 25 November 2019 |
| Primary completion | 1 April 2020 |
| Estimated completion | 1 April 2020 |
| Sites | 1 location across Austria |
Drugs / interventions tested
- biometric measurement IOLMaster 700
- biometric measurement Lenstar LS 700
- biometric measurement Anterion Heildelberg
Conditions studied
- Cataract Senile — all drugs for Cataract Senile →
Sponsor
Prim. Prof. Dr. Oliver Findl, MBA
Who can join
Adults 21 to 100, any sex, with Cataract Senile. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Achieving high accuracy and precision in ocular biometry has become primordial for cataract surgery, due to the shift of cataract surgery from a rehabilitation procedure to a refractive one. Aim of this study is to determine the repeatability of ocular biometric parameters obtained using three biometry devices, two ss-OCT biometers and an OLCR device.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT04255706
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Cataract Senile
Currently open trials in the same condition.
- NCT04570579 — Impact of a Novel Extended Depth of Focus Intraocular Lens on Visual and Lifestyle Enhancement · active not recruiting
Other Prim. Prof. Dr. Oliver Findl, MBA trials
Trials by the same sponsor.
- NCT07425626 — Brillouin Scanning in Cataractous Eyes · active not recruiting
- NCT06624826 — Visual Performance of an Extended Depth of Focus IOL in an Emmetropic or Monovision Modality · NA · recruiting
- NCT06459284 — Instrument Tissue Interaction at the Grasp Site During Membrane Peeling of Epiretinal Membranes · completed
- NCT06948851 — New Postoperative Intraretinal Cystoid Changes After Vitrectomy With Membrane Peeling Due to Epiretinal Membranes · active not recruiting
- NCT07436247 — Pseudophakic Eyes With Presbyopia-correcting IOLs: OCT Biometry and Pyramid Aberrometry · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04255706 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Prim. Prof. Dr. Oliver Findl, MBA
- Last refreshed: 1 October 2020
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04255706.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing